comprehensive -WSS

comprehensive

author：comprehensive 2025-09-28 21:04:55 - browse：9

Ron Wyden (left), Mike Crapo (right) -- health policy coverage from STAT — Draft legislation authored by Senate Finance Chair Ron Wyden (D-Ore.) and ranking member Mike Crapo (R-Idaho) includes several measures to regulate how pharmacy benefit managers are paid by health plans to negotiate with drugmakers. Pete Marovich-Pool/Getty Images

WASHINGTON — A key Senate health care panel has developed a plan to tackle reforms to middlemen in the pharmacy drug payment system, according to bill text obtained by STAT.

The draft legislation, authored by Senate Finance Chair Ron Wyden (D-Ore.) and ranking member Mike Crapo (R-Idaho), includes several measures to regulate how pharmacy benefit managers are paid by health plans to negotiate with drugmakers.

The most significant measure is a bill from Sens. Bob Menendez (D-N.J.) and Marsha Blackburn (R-Tenn.) that would prohibit PBMs from getting any income outside of service fees, and prohibits those service fees from being related to drugs’ list prices.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： A new initiative will help leaders fight the next pandemic

WSS

FDA approves Moderna’s RSV vaccine, its second licensed product

R1 RCM gets $5.8 billion buyout offer from private equity firm

The Harvard botanist who searched for psychedelics in the Amazon

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

R1 RCM gets $5.8 billion buyout offer from private equity firm

Antivenom research: Lessons from HIV applied in search for universal antidote

focus

comprehensive

knowledge

Psychedelics group wrestles with new pharma identity

Illumina board agrees to spin off Grail, as divestment plans proceed

New air purifier tech could be key to improving indoor air quality

ASCO Takeaways: Winners, snoozers, and the art of cancer care

Guidelines to prevent youth baseball injuries need more muscle

6 phony surgeries that take placebo to the extreme

DIEP, the 'gold standard' of breast reconstruction, is under threat

6 phony surgeries that take placebo to the extreme

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Illumina board agrees to spin off Grail, as divestment plans proceed

focus

R1 RCM gets $5.8 billion buyout offer from private equity firm

ASCO Daily Recap: CAR

The most pressing bird flu mysteries scientists want answered

He's a Nobel laureate. Critics say he was misleading on Covid

Eli Lilly’s Zepbound improved liver scarring in mid

The Readout: Abbvie and Humira, CRISPR in utero, Annovis Bio

explore

hotspot

hotspot

hotspot